Large gap with delayed quotes
|
Last quote
12/27/2024 -
20:00:00
|
Bid
12/27/2024 -
15:59:59
|
Bid Volume |
Ask
12/27/2024 -
15:59:59
|
Ask Volume |
|---|---|---|---|---|
|
113.95
+0.18
(
+0.16% )
|
113.93
|
900 |
114.24
|
100 |
Analysis date: 24.12.2024
Global Evaluation
Slightly negative
Slightly negative
The stock is classified in the slightly negative zone since 12.11.2024.
Interest
None
None
No interest since 24.12.2024.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 26.11.2024 at a price of 118.54.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, at its current price the stock is strongly overvalued.
MT Tech Trend
Neutral
Neutral
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 20.12.2024), the stock traded below its moving average. The confirmed Technical Reverse (Tech Reverse + 1.75%) point is
4wk Rel Perf
-6.37%
-6.37%
The four week relative underperformance versus SP500 is 6.37%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 12.11.2024.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.34%.
Mkt Cap in $bn
27.21
27.21
With a market capitalization >$8bn, BIONTECH SE is considered a large-cap stock.
G/PE Ratio
-0.50
-0.50
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-36.93
-36.93
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-18.49%
-18.49%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
17
17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
100
100
For 1% of index variation, the stock varies on average by 1.00%.
Correlation
0.29
0.29
Stock movements are strongly independent of index variations.
Value at Risk
27.39
27.39
The value at risk is estimated at USD 27.39. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.07.2021
02.07.2021